Table 1.
Commercially marketed medicinal products of self-emulsifying drug delivery systems (SEDDS) formulations.
| API 1 | BCS Class 2 | Product Name/Company (Strength, mg) | Dosage Form |
|---|---|---|---|
| Cyclosporin | IV | Sandimmune®/Novartis | Soft gelatin capsule |
| - | - | Neoral®/Novartis | Soft gelatin capsule |
| - | - | Gengraf®/AbbVie | Hard gelatin capsule |
| Ritonavir | II | Norvir®/AbbVie | Soft gelatin capsule |
| Saquinavir | IV | Fortovase®/Roche | Soft gelatin capsule |
| Amprenavir | II | Agenerase®/GlaxoSmithKline | Soft gelatin capsule |
| Valproic acid | II | Depakene®/AbbVie | Soft gelatin capsule |
| Calcitriol | II | Rocaltrol®/Roche | Soft gelatin capsule |
| Bexarotene | II | Targretin®/Ligand | Soft gelatin capsule |
| Tretinoin | II | Vesanoid®/Roche | Soft gelatin capsule |
| Isotretinoin | II | Accutane®/Roche | Soft gelatin capsule |
| Tipranavir | II | Aptivus®/Boehringer Ingelheim | Soft gelatin capsule |
1 Active pharmaceutical ingredient, 2 Biopharmaceutics Classification System.